...
机译:以蛋白质生物芯片为特征的TNF-α抑制剂的脱靶活性
Department of Pediatric Oncology Hematology and Clinical Immunology Jeffrey Modell Immunodeficiency Center University Children’s Hospital Düsseldorf 40225 Düsseldorf Germany;
Protagen AG Otto-Hahn-Str.15 44227 Dortmund Germany;
Ruhr-University Bochum Medizinisches Proteom-Center Universitätsstraße 150 44780 Bochum Germany;
Ruhr-University Bochum Medizinisches Proteom-Center Universitätsstraße 150 44780 Bochum Germany;
Ruhr-University Bochum Medizinisches Proteom-Center Universitätsstraße 150 44780 Bochum Germany;
Department of Pediatric Oncology Hematology and Clinical Immunology Jeffrey Modell Immunodeficiency Center University Children’s Hospital Düsseldorf 40225 Düsseldorf Germany;
Department of Pediatric Oncology Hematology and Clinical Immunology Jeffrey Modell Immunodeficiency Center University Children’s Hospital Düsseldorf 40225 Düsseldorf Germany;
Specificity analysis; Off-target activity; Adalimumab; Etanercept; Infliximab; Protein biochip;
机译:以蛋白质生物芯片为特征的TNF-α抑制剂的脱靶活性
机译:基于活性的蛋白谱分析揭示了FAAH抑制剂BIA 10-2474的脱靶蛋白
机译:硅酰基氨基酶和脂肪酶抑制剂的硅酸酯和脂肪酶抑制剂脱脂IP
机译:Lenainaldide类似物作为TNF-α抑制剂的定量结构 - 活性模型
机译:热处理对小扁豆总酚含量,抗氧化活性,胰蛋白酶抑制剂活性和体外蛋白质消化率的影响
机译:基于活性的蛋白谱分析揭示了FAAH抑制剂BIA 10-2474的脱靶蛋白
机译:使用蛋白质生物芯片和组织微阵列确定和验证抗CD44变体6抗体的脱靶活性